Aggressive regimens for multidrug-resistant tuberculosis decrease all-cause mortality (Q28487938)

3

Michael L

Rich

1 reference

20 October 2023

Felix A Alcantara Viru

4

Felix A

Alcantara Viru

1 reference

20 October 2023

Sasha C Appleton

5

Sasha C

Appleton

1 reference

20 October 2023

Sidney S Atwood

6

Sidney S

Atwood

1 reference

20 October 2023

Jaime N Bayona

7

Jaime N

Bayona

1 reference

20 October 2023

Katiuska Chalco

9

Katiuska

Chalco

1 reference

20 October 2023

Hamish S F Fraser

10

Hamish S F

Fraser

1 reference

20 October 2023

Dalia Guerra

12

Dalia

Guerra

1 reference

20 October 2023

Rocio M Hurtado

13

Rocio M

Hurtado

1 reference

20 October 2023

Keith Joseph

14

Keith

Joseph

1 reference

20 October 2023

Karim Llaro

15

Karim

Llaro

1 reference

20 October 2023

Lorena Mestanza

16

Lorena

Mestanza

1 reference

20 October 2023

Joia S Mukherjee

17

Joia S

Mukherjee

1 reference

20 October 2023

Maribel Muñoz

18

Maribel

Muñoz

1 reference

20 October 2023

Eda Palacios

19

Eda

Palacios

1 reference

20 October 2023

Epifanio Sanchez

20

Epifanio

Sanchez

1 reference

20 October 2023

Kwonjune J Seung

21

Kwonjune J

Seung

1 reference

20 October 2023

Sonya S Shin

22

Sonya S

Shin

1 reference

20 October 2023

Alexander Sloutsky

23

Alexander

Sloutsky

1 reference

20 October 2023

Arielle W Tolman

24

Arielle W

Creative Commons Attribution 4.0 International

Tolman

1 reference

20 October 2023

language of work or name

English

0 references

publication date

2013

0 references

published in

PLOS One

0 references

volume

8

0 references

page(s)

e58664

0 references

issue

3

0 references

copyright license

start time

13 March 2013

1 reference

April 2022 Public Data File from Crossref

copyright status

copyrighted

0 references

cites work

Treatment outcomes of multidrug-resistant tuberculosis: a systematic review and meta-analysis

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3596279

The diarylquinoline TMC207 for multidrug-resistant tuberculosis

19 March 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3596279

Scaling up programmatic management of drug-resistant tuberculosis: a prioritized research agenda

19 March 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3596279

GRADE: an emerging consensus on rating quality of evidence and strength of recommendations

19 March 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3596279

Global incidence of multidrug-resistant tuberculosis

19 March 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3596279

Community-based therapy for multidrug-resistant tuberculosis in Lima, Peru

19 March 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3596279

19 March 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3596279

Aggressive regimens for multidrug-resistant tuberculosis reduce recurrence

19 March 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3596279

Strategies for reducing treatment default in drug-resistant tuberculosis: systematic review and meta-analysis.

29 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3596279

Transmission of multidrug-resistant and extensively drug-resistant tuberculosis in a metropolitan city

29 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3596279

Outcome of standardized treatment for patients with MDR-TB from Tamil Nadu, India

29 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3596279

Increasing drug resistance in extensively drug-resistant tuberculosis, South Africa

29 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3596279

Short, highly effective, and inexpensive standardized treatment of multidrug-resistant tuberculosis

29 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3596279

Development of extensively drug-resistant tuberculosis during multidrug-resistant tuberculosis treatment

29 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3596279

Analysis of individual drug use as a time-varying determinant of exposure in prospective population-based cohort studies

29 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3596279

High level of cross-resistance between kanamycin, amikacin, and capreomycin among Mycobacterium tuberculosis isolates from Georgia and a close relation with mutations in the rrs gene

29 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3596279

Fluoroquinolone resistance in Mycobacterium tuberculosis and mutations in gyrA and gyrB.

29 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3596279

Emergence of new forms of totally drug-resistant tuberculosis bacilli: super extensively drug-resistant tuberculosis or totally drug-resistant strains in iran.

29 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3596279

Fluoroquinolone resistance in Mycobacterium tuberculosis: an assessment of MGIT 960, MODS and nitrate reductase assay and fluoroquinolone cross-resistance

29 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3596279

Treatment outcomes among patients with multidrug-resistant tuberculosis: systematic review and meta-analysis

29 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3596279

Comprehensive treatment of extensively drug-resistant tuberculosis.

29 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3596279

Risk factors and mortality associated with default from multidrug-resistant tuberculosis treatment

29 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3596279

Multidrug-resistant and extensively drug-resistant Mycobacterium tuberculosis: epidemiology and control.

29 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3596279

Nurses as providers of emotional support to patients with MDR-TB.

29 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3596279

Functional analysis of DNA gyrase mutant enzymes carrying mutations at position 88 in the A subunit found in clinical strains of Mycobacterium tuberculosis resistant to fluoroquinolones

29 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3596279

Surgery for patients with drug-resistant tuberculosis: report of 121 cases receiving community-based treatment in Lima, Peru

29 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3596279

Treatment of multidrug-resistant tuberculosis: evidence and controversies.

29 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3596279

Speaking the same language: treatment outcome definitions for multidrug-resistant tuberculosis.

29 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3596279

Time-dependent bias was common in survival analyses published in leading clinical journals.

29 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3596279

Programmes and principles in treatment of multidrug-resistant tuberculosis

29 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3596279

Fluoroquinolones, tuberculosis, and resistance

29 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3596279

Informatics tools to monitor progress and outcomes of patients with drug resistant tuberculosis in Peru

29 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3596279

Feasibility and cost-effectiveness of standardised second-line drug treatment for chronic tuberculosis patients: a national cohort study in Peru

29 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3596279

Standard short-course chemotherapy for drug-resistant tuberculosis: treatment outcomes in 6 countries

2 June 2018

1 reference

https://api.crossref.org/works/10.1371%2FJOURNAL.PONE.0058664

Outcome of MDR-TB patients, 1983-1993. Prolonged survival with appropriate therapy.

21 January 2018

1 reference

https://api.crossref.org/works/10.1371%2FJOURNAL.PONE.0058664

Outcome of multi-drug-resistant tuberculosis in France: a nationwide case-control study.

21 January 2018

1 reference

https://api.crossref.org/works/10.1371%2FJOURNAL.PONE.0058664

HIV-positive patients treated for multidrug-resistant tuberculosis: clinical outcomes in the HAART era.

21 January 2018

1 reference

https://api.crossref.org/works/10.1371%2FJOURNAL.PONE.0058664

Totally drug-resistant tuberculosis in India.

21 January 2018

1 reference

https://api.crossref.org/works/10.1371%2FJOURNAL.PONE.0058664

WHO guidelines for the programmatic management of drug-resistant tuberculosis: 2011 update

21 January 2018

1 reference

https://api.crossref.org/works/10.1371%2FJOURNAL.PONE.0058664

Encouraging News for Multidrug-resistant Tuberculosis Treatment

21 January 2018

1 reference

https://api.crossref.org/works/10.1371%2FJOURNAL.PONE.0058664

Identifying early treatment failure on category I therapy for pulmonary tuberculosis in Lima Ciudad, Peru.

21 January 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3596279

Drug resistance among failure and relapse cases of tuberculosis: is the standard re-treatment regimen adequate?

27 November 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3596279

[Improved prognosis in HIV/AIDS related multi-drug resistant tuberculosis patients treated with highly active antiretroviral therapy]

27 November 2018

1 reference

12 December 2020

Recurrence after Treatment for Pulmonary Multidrug‐Resistant Tuberculosis

1 reference

12 December 2020

Representative drug susceptibility patterns for guiding design of retreatment regimens for MDR-TB

1 reference

12 December 2020

Time to sputum culture conversion in multidrug-resistant tuberculosis: predictors and relationship to treatment outcome

1 reference

12 December 2020

10.1371/JOURNAL.PONE.0058664

Identifiers

DOI

1 reference

2786851

ADS bibcode

2013PLoSO...858664M

0 references

2786851

1 reference

1 reference

1 reference